Skip to main content

Table 2 Virological breakthrough during the study

From: Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections

Patient (Pn)

Group

Breakthrough time (Week)

Mutation

Rescue therapy

P1

LDT

36

M204I

LDT + ADV

P2

LDT

52

M204I

LDT + ADV

P3

LDT

52

M204V

LDT + ADV

P4

LDT

52

L180M

LDT + ADV

P5

LDT + ADV

52

M204V

TDF

P6

LDT + ADV

52

M204V

TDF